Name | DRUG, OOO |
|---|
INN | 7704029400 |
|---|
KPP | 770401001 |
|---|
OGRN | 1027700231019 |
|---|
OKPO | 17113990 |
|---|
Address | 119121, G.moskva, ul. Plyuschikha, d. D.9-9A |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 68.20.2 | Core activity | Renting and operating of own or leased commercial properties and non- residential buildings | | 16.23 | Additional activity | Manufacture of other builders' carpentry and joinery | | 41.20 | Additional activity | Construction of buildings | | All types of activities | | 46.19 | Additional activity | Activity of agents in wholesale trade of universal assortment of goods | | 46.90 | Additional activity | Nonspecialised wholesale trade | | 47.7 | Additional activity | Retail sale of other goods in specialised stores | | 56.10 | Additional activity | Activity of restaurants and services for the delivery of food | | 56.10.1 | Additional activity | Traditional restaurants | | 56.10.3 | Additional activity | Snack bars, etc. | | 68.2 | Additional activity | Renting and operating of own or leased real estate | | 68.31 | Additional activity | Procurement of land, buildings and homes for others | | 68.32 | Additional activity | Management of land, buildings and homes for others | | 69.10 | Additional activity | Legal activities | | 71.11 | Additional activity | Architectural activities | | 72.19 | Additional activity | Research and experimental development on natural sciences and engineering Other | | 73.11 | Additional activity | Activities of advertising agencies | | 73.20.1 | Additional activity | Market and opinion research |
Registration date | 18.09.2002 |
|---|
Registering department | Gosudarstvennoe uchrezhdenie Moskovskaya registratsionnaya palata |
|---|
|
DRUG, OOO (Moscow; INN 7704029400) was registered on 18 Sep 2002. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of DRUG, OOO - Limited liability companies. Form of ownership of DRUG, OOO - Private property. Principal activities of DRUG, OOO: renting and operating of own or leased commercial properties and non- residential buildings (68.20.2), manufacture of other builders' carpentry and joinery (16.23), construction of buildings (41.20). |
Economic indicators2023
Net profit (RAS) of DRUG, OOO grew over 2023 13.81 times to 1.37 million RUB from 99.00 thousand RUB over 2022, the company informed. Revenue increased in the accounting period by 11.87% to 12.70 million RUB from 11.35 million RUB over 2022; cost of goods sold decreased by 3.69% to 10.50 million RUB from 10.90 million RUB; sales profit went up 4.88 times to 2.20 million RUB from 451.00 thousand RUB. 2022
Net profit (RAS) of DRUG, OOO made up 99.00 thousand RUB over 2022 compared to net loss of 2.49 million RUB over 2021, the company informed. Revenue decreased in the accounting period by 4.59% to 11.35 million RUB from 11.90 million RUB in 2021; cost of goods sold decreased by 33.88% to 10.90 million RUB from 16.49 million RUB; sales profit made up 451.00 thousand RUB compared to sales loss of 4.59 million RUB. 2021
Net loss (RA) of DRUG, OOO made up 2.49 million RUB over 2021 compared to net profit of 1.43 million RUB over 2020, the company informed. Revenue increased in the accounting period by 17.24% to 11.90 million RUB from 10.15 million RUB over 2020; cost of goods sold grew 1.96 times to 16.49 million RUB from 8.39 million RUB; sales loss made up 4.59 million RUB compared to sales profit of 1.76 million RUB. 2020
Net profit (RAS) of DRUG, OOO made up 1.43 million RUB over 2020 compared to net loss of 269.00 thousand RUB over 2019, the company informed. Revenue decreased in the accounting period by 8.90% to 10.15 million RUB from 11.14 million RUB in 2019; cost of goods sold grew by 8.85% to 8.39 million RUB from 7.71 million RUB; sales profit fell by 48.78% to 1.76 million RUB from 3.43 million RUB. 2019
Net loss (RAS) of DRUG, OOO increased by 5.08% to 269.00 thousand RUB from 256.00 thousand RUB over 2018, the company informed. Revenue increased in the accounting period by 44.71% to 11.14 million RUB from 7.70 million RUB over 2018; cost of goods sold grew by 36.23% to 7.71 million RUB from 5.66 million RUB; sales profit went up 1.68 times to 3.43 million RUB from 2.04 million RUB. 2018
Net loss (RA) of DRUG, OOO made up 256.00 thousand RUB over 2018 compared to net profit of 867.00 thousand RUB over 2017, the company informed. Revenue increased in the accounting period by 8.06% to 7.70 million RUB from 7.13 million RUB over 2017; cost of goods sold grew by 37.25% to 5.66 million RUB from 4.12 million RUB; sales profit fell by 32.05% to 2.04 million RUB from 3.00 million RUB. 2017
Net profit (RAS) of DRUG, OOO dropped in 2017 3.76 times to 867.00 thousand RUB from 3.26 million RUB over the same period in 2016, the company informed. Revenue increased in the accounting period by 8.32% to 7.13 million RUB from 6.58 million RUB over 2016; sales profit fell by 14.76% to 3.00 million RUB from 3.52 million RUB. 2016
Net profit (RAS) of DRUG, OOO dropped in 2016 by 16.04% to 3.26 million RUB from 3.88 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 6.64% to 6.58 million RUB from 7.05 million RUB in 2015; sales profit fell by 15.05% to 3.52 million RUB from 4.15 million RUB. 2014
Net profit (RAS) of DRUG, OOO grew over 2014 by 43.51% to 4.99 million RUB from 3.48 million RUB over 2013, the company informed. Revenue increased in the accounting period by 24.26% to 8.09 million RUB from 6.51 million RUB over 2013; cost of goods sold grew by 1.51% to 2.82 million RUB from 2.78 million RUB; sales profit went up by 41.23% to 5.27 million RUB from 3.73 million RUB. 2013
Net profit (RAS) of DRUG, OOO grew over 2013 by 40.03% to 3.48 million RUB from 2.48 million RUB over 2012, the company informed. Revenue increased in the accounting period by 22.17% to 6.51 million RUB from 5.33 million RUB over 2012; cost of goods sold grew by 28.23% to 2.78 million RUB from 2.17 million RUB; sales profit went up by 18.01% to 3.73 million RUB from 3.16 million RUB. 2012
Net profit (RAS) of DRUG, OOO grew over 2012 by 0.65% to 2.48 million RUB from 2.47 million RUB over 2011, the company informed. Revenue increased in the accounting period by 7.83% to 5.33 million RUB from 4.94 million RUB over 2011; cost of goods sold grew by 21.12% to 2.17 million RUB from 1.79 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|